Home > News > Dr. Shelly Gunn Joins CombiMatrix Molecular Diagnostics
July 24th, 2006
Dr. Shelly Gunn Joins CombiMatrix Molecular Diagnostics
Abstract:
Acacia Research Corporation (Nasdaq:CBMX)(Nasdaq:ACTG) announced today that Dr. Shelly Gunn, M.D., Ph.D., has joined CombiMatrix Molecular Diagnostics (CMDX) as its Medical Director.
Source:
businesswire
Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||